News Releases

Below are the latest News Releases for Clearmind Medicine Inc.

14

October

Clearmind Medicine Appoints Distinguished Addiction Experts
Read More
13

October

Clearmind Medicine Files Provisional Patent Application
Read More
7

October

Clearmind Medicine Partners With Clinipace
Read More
1

October

Clearmind Medicine to Host ‘Psychedelics for Alcoholism‘ Virtual Educational Event on October 20
Read More
27

September

Clearmind Medicine To Fund Second R&D Partnership With Hebrew University's Technology Transfer Company
Read More
21

September

Clearmind Medicine Partners with The Hebrew University to Develop Novel Psychedelic Drug
Read More
2

September

Oded Gilboa and Oz Adler Appointed to Board of Directors
Read More
18

August

Clearmind Medicine Commences Trading On The Frankfurt Stock Exchange
Read More
3

August

Mark Haden, Psychedelic Medicine Expert, Joins Clearmind Medicine’s Advisory Board
Read More
20

July

A letter to shareholders from its Chief Executive Officer Dr. Adi Zuloff-Shani.
Read More
2

July

Clearmind Medicine Inc. Retains Edge Communications Group for Investor Relations and Announces Granting of Stock Options
Read More
30

June

Clearmind Medicine Inc. Announces Closing of Previously Announced Private Placements for Aggregate Gross Proceeds of CAD$6.225...
Read More
20

June

Clearmind Medicine Inc. Announces Increase to Previously Announced Non-Brokered Private Placement
Read More
27

May

Clearmind Medicine Inc. Announces Non-Brokered Private Placement and Granting of Stock Options
Read More
25

May

Cyntar Ventures Inc. Completes Change of Business Listing as it Shifts Focus to Psychoactive Pharmaceuticals for Underserved...
Read More